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ABSTRACT
The Evidence-based Toxicology Collaboration hosted a workshop on “The Emergence of Systematic Review and Related
Evidence-based Approaches in Toxicology,” on November 21, 2014 in Baltimore, Maryland. The workshop featured speakers
from agencies and organizations applying systematic review approaches to questions in toxicology, speakers with experience
in conducting systematic reviews in medicine and healthcare, and stakeholders in industry, government, academia, and nongovernmental organizations. Based on the workshop presentations and discussion, here we address the state of systematic
review methods in toxicology, historical antecedents in both medicine and toxicology, challenges to the translation of
systematic review from medicine to toxicology, and thoughts on the way forward. We conclude with a recommendation that
as various agencies and organizations adapt systematic review methods, they continue to work together to ensure that there
is a harmonized process for how the basic elements of systematic review methods are applied in toxicology.
Key words: systematic review; risk of bias; data integration.

The Evidence-based Toxicology Collaboration (EBTC) is a group
of North American and European researchers from government,
academia, and industry who are interested in applying systematic review methods to toxicology (EBTC, 2015). The EBTC
hosted a workshop on “The Emergence of Systematic Review
and Related Evidence-based Approaches in Toxicology,” on

November 21, 2014 at the Johns Hopkins Bloomberg School of
Public Health, in Baltimore, Maryland, USA. The workshop featured speakers from agencies and organizations developing and
applying systematic review methods to questions in toxicology,
speakers with experience in conducting systematic reviews in
medicine and healthcare, and stakeholders from industry,
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TABLE 1. The basic steps of a typical systematic review.
1.
2.
3.
4.
5.
6.
7.
8.
9.

Formulating a focused research question.
Preparing a protocol.
Applying the pre-defined literature search strategy.
Selecting the relevant papers by applying pre-defined inclusion
and exclusion criteria.
Assessing the risk of bias of the included studies.
Extracting data on both the results relevant for addressing the
research question and the study methods.
Synthesizing the data.
Rating the certainty in the findings.
Interpreting the results and presenting a summary of findings.

of systematic review methods, these organizations’ approaches
share commonalities including the fundamental steps of a systematic review.

SYSTEMATIC REVIEW METHODOLOGY AS
APPLIED TO TOXICOLOGY
The initial steps of systematic review begin with scoping and
problem formulation to identify the question of interest, gain a
sense of the relevant literature, define and refine the question,
define a PECO statement (see below), and develop the review
protocol. Formulating the question to be answered is a simplesounding process but it requires careful deliberation because
the question guides the review. Then, a PECO statement is developed to identify the population (P), exposure (E), comparisons
(C), and outcome (O) of interest to address the review question
(European Food Safety Authority, 2010). This PECO statement is
used to develop the literature search criteria and the inclusion/
exclusion criteria for selecting the evidence relevant to answering the research question (Krauth et al., 2013).
A subsequent step is evaluating the risk of bias or methodological quality of the included studies, as pre-specified in the review protocol. Methodological quality refers to all aspects of a
study’s design, conduct, analysis, and outcome reporting that
influence the study’s ability to accurately answer the question
posed. Risk of bias is a major component of methodological
quality and refers to systematic errors that may lead to either
an overestimation or an underestimation of the true effect
(Higgins and Green, 2011). Shortcomings in the design, conduct,
analysis, and outcome reporting of experiments add to the “risk
of bias” or reduce methodological quality. The explicit evaluation of study bias is an important feature of systematic review
historically and one not considered in traditional toxicology literature reviews. Examples of risks of bias include failure to (1)
adequately randomize the administered dose or exposure level
to each research subject in clinical trials or experimental studies, (2) account for important confounding or modifying variables, and (3) report all measured outcomes (Rooney et al., 2014).
Dose selection per se, obviously an important issue in toxicology, is usually not considered a risk of bias issue. Rather, it is an
element of external validity (or directness, applicability, and the
extent to which a study’s finding can be generalized to other circumstances). It remains to be determined to what extent issues
of methodological quality beyond risk of bias should be incorporated in quality assessments in systematic reviews in toxicology, and the extent to which such issues are reported in
research papers and thus amenable to assessment.
A growing number of tools have been developed to assess
the risk of bias of environmental health studies (Krauth et al.,
2013). There are published risk of bias frameworks for epidemiological studies and animal studies, but no such tools for in vitro
studies or mechanistic data (Samuel et al., in press). However,
there is a published approach in which mechanistic data are assessed for both methodological and reporting quality. The
ToxRTool was created with funding from the European
Commission and uses Klimisch codes (1 ¼ reliable without restriction, 2 ¼ reliable with restrictions, 3 ¼ not reliable, and 4
¼ not assignable) (Klimisch et al., 1997) to evaluate and categorize the quality of toxicological data, including in vitro studies
(Schneider et al., 2009).
Another major step in applying systematic review
approaches to toxicology is integrating the evidence within and
across diverse study types (eg, in vivo, in vitro, and human
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government, academia, and non-governmental organizations.
The full program and a brief summary are available online
(EBTC, 2015). In this article, we expand on the workshop presentations to look at the use of systematic review approaches in
toxicology, their roots in medicine and healthcare, the challenges facing practitioners, and some thoughts on the way forward, including implications for toxicologists in designing and
reporting their studies.
Systematic review methods constitute a standardized approach for identifying and analyzing evidence related to clearly
formulated questions (Higgins and Green, 2011; Institute of
Medicine, 2011). Systematic reviews proceed through a sequence of steps, typically formulating a specific research question, developing a review protocol, performing a comprehensive
literature search, selecting relevant studies, assessing the risk
of bias of included studies, extracting and synthesizing the
study data, rating the certainty in the findings, and interpreting
and summarizing the findings (Table 1).
Compared to traditional narrative reviews, the systematic
review framework is aimed at minimizing subjectivity and enhancing transparency, rigor, and consistency in the way reviews
are conducted and reported (Silbergeld and Scherer, 2013).
Transparency is enhanced through the drafting and posting of a
protocol prior to commencing the review. The protocol specifies
the research question; the literature search strategy; the inclusion/exclusion criteria for identifying relevant studies returned
in the literature search; the framework for judging the quality of
included studies; and the plan for data analysis, synthesis and
presentation of findings. In this way, clear criteria for conducting the review are developed and specified in advance.
Although a systematic review approach increases the transparency and objectivity in the process, the conclusions of such reviews rely on the scientific judgment of the reviewers. Therefore,
it is important to note that multiple reviews of a given topic will
not necessarily address the same set of studies or come to the
same conclusion. The basis of the scientific judgments and the
conclusions should be made clear in a systematic review.
Some of the advantages and disadvantages of systematic review approaches are summarized in Table 2.
Systematic review methods, first developed for clinical medicine, have been adapted and are being used by toxicologists to
synthesize available evidence, eg, on the potential association
of exposure to a chemical with a particular health effect. The US
National Toxicology Program, the US Environmental Protection
Agency’s Integrated Risk Information System program, the
European Food Safety Authority, the Evidence-based Toxicology
Collaboration, the UCSF Navigation Guide, and others are implementing systematic review methods in ways that meet their diverse programmatic needs. Despite their different applications
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TABLE 2. Some advantages and disadvantages of systematic reviews.

observational studies), in order to reach a conclusion. Data integration frameworks should be true to the evidence-based principles of transparency, objectivity, and consistency.
Groups of scientists in both the United States and European
Union are collaborating to advance systematic review
approaches in toxicology. Guidance for conducting systematic
reviews in toxicology has been published (European Food Safety
Authority, 2010; Rooney et al., 2014; Woodruff and Sutton, 2014).
There is substantial consistency across the approaches that
have been developed in terms of how they frame the review (developing a specific research question and PECO statement),
identify the evidence, evaluate its study quality (eg, by using
risk of bias tools), and rate the certainty in the findings. The certainty rating in these approaches has been based on the GRADE
approach, a system for evaluating the quality of the body of evidence, which is widely accepted in healthcare (Guyatt et al.,
2011).

AGENCY FRAMEWORKS AND OTHER EFFORTS
The Office of Health Assessment and Translation (OHAT) of the
National Institute of Environmental Health Sciences has created
a framework for applying systematic review methods to environmental health questions, including methods to develop conclusions from the full range of relevant data (human, animal
and in vitro data) (Rooney et al., 2014). The OHAT approach was
developed in a process involving public comment and consultation with experts from toxicology and systematic review, building on and extending guidance from major systematic review
groups (eg, the Cochrane Collaboration (Higgins and Green,
2011), Agency for Healthcare Research and Quality
(Viswanathan et al., 2013), GRADE Workgroup (Guyatt et al.,
2011), and the Navigation Guide Work Group (Woodruff and
Sutton, 2014)). The evaluation process begins with a problem
formulation step to form the specific research question and the
PECO statement, and then involves the development of a protocol for conducting the review. The protocol outlines the methods for the evaluation tailored to the research question,
including the literature search strategy, inclusion/exclusion criteria, risk of bias approach, establishing confidence in the evidence, and methods for evidence integration.

In the OHAT framework, evidence integration begins with
the process for rating confidence in the findings for each body
of evidence separately (eg, human and animal studies on a particular outcome) based on the GRADE approach (Guyatt et al.,
2008) with modifications on the initial starting point for observational human studies. It includes guidance for human and
animal studies and a process for considering mechanistic studies. Rating confidence in the body of evidence is developed using the GRADE factors that reflect strengths and weaknesses of
a body of evidence (eg, dose response, or indirectness) with an
additional factor that may increase confidence in the association between exposure and health outcome when there is consistency of the response across species, study designs, or
human populations. These ratings are translated into levels of
evidence for each health effect based on whether the reviewed
studies do or do not show an adverse effect. Finally, the degree
of support from mechanistic studies is considered and the 3 evidence streams (human, animal, mechanistic) are integrated to
reach a hazard conclusion of “known,” “presumed,” “suspected,” or “not classifiable” as a hazard to humans that reflects
the confidence and consistency across each body of evidence.
OHAT released a detailed methods guide of standard operating procedures for using systematic review in its evaluations in
2014 (National Toxicology Program, 2015). This guide reflected
OHAT’s then-current practices, with the expectation that the
procedures will be updated and refined as best practices in the
field of environmental health and systematic review continue
to evolve.
The US Environmental Protection Agency’s Integrated Risk
Information System (IRIS) program is adapting and implementing systematic review methods (US Environmental Protection
Agency, 2015a). These procedures, modeled after the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins and
Green, 2011), also reflect recommendations from 2 US National
Research Council (NRC) reviews of the IRIS process (National
Research Council, 2011; National Research Council, 2014).
IRIS assessments involve multiple systematic reviews to determine whether a chemical causes specific adverse effects, eg,
for endpoints such as carcinogenicity or neurotoxicity, in humans or in animals. The data include mainly animal and in vitro
studies, and observational epidemiological studies. IRIS
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Advantages.
A protocol for how the review will be conducted—written in advance—reduces the likelihood that ad hoc changes will be made that bias the
outcomes. In cases where the protocol is published or otherwise shared with interested parties in advance of the actual review, stakeholders
are thereby given the opportunity to recommend changes.
The incorporation of explicit criteria for including and excluding individual studies gives readers of the review a clear rationale for why some
studies were included or excluded.
Assessing the risk of bias or broader methodological quality of the included studies gives reviewers and readers a sense of how much confidence to have in the review’s conclusions.
Reviews that assess certain studies as having a high risk of bias are likely to encourage the authors of those studies to improve the quality of
their future research.
The explicit and transparent nature of the review process and its published review give readers a clear sense of how the review was carried
out. This also enables interested parties to replicate the review, with or without making any protocol amendments deemed desirable.
Under certain conditions, data synthesis lends itself to meta-analysis, which provides a quantitative summary of the data from individual
studies and overall.
Disadvantages.
Even once familiar with the process and tools, conducting a systematic review is still likely to take considerable time and labor. Review teams
are likely to include, at a minimum, an information specialist, a systematic review “methodologist,” and subject-matter experts.
Although the basic framework for systematic reviews has remained the same across the fields to which it has been applied already, those seeking to apply this methodology to a new field will likely face some challenges not fully addressed by the experience gained in these other
fields.
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based on the recognition that evidence is needed in all assessments and the process for collecting, appraising, and analyzing
it should be the same regardless of the objectives of the assessment or who conducts it. Assessments focused on efficacy,
safety, and risk should all follow the same process. Another rationale for the Prometheus project is to address the issues presented when evidence is not available or there is insufficient
time for applying extensive or complex approaches. EFSA recently published a report on the resulting methodological
framework (European Food Safety Authority, 2015b). The
Authority is also working on a report on how to analyze data
gaps and the impacts thereof.
The EBTC is particularly interested in the Cochrane
Collaboration’s emerging methodology for systematic reviews
of diagnostic test accuracy in medicine (Cochrane
Collaboration, 2015) and its application to test method assessment in toxicology (Hoffmann and Hartung, 2005). The EBTC is
using this approach to conduct a systematic review of zebrafish
embryo testing as a predictor of developmental toxicity (de
Vries et al., 2014). The aim is determine how well zebrafish embryo testing identifies teratogenesis, as compared to results
from standard mammalian test protocols in rats and rabbits.
A primary driver for this review is to identify whether the
zebrafish could serve as a partial replacement for the routine
test for prenatal development, Test Guideline 414 of the
Organisation for Economic Cooperation and Development. This
test is costly in terms of money, time, and animals (primarily
rats and rabbits) (Selderslaghs et al., 2009).

ANTECEDENTS
Systematic reviews are the hallmark of evidence-based medicine, which has been defined as the conscientious, explicit and
judicious use of current best evidence in making decisions
about the care of individual patients (Sackett et al., 1996).
Evidence-based medicine involves integrating individual clinical expertise with the best available external evidence from systematic research (Sackett et al., 1996). The creation of
organizations that shaped and promoted evidence-based medicine, such as the Cochrane Collaboration, facilitated the development of rigorous methods (Cochrane Collaboration, 2015).
Systematic reviews have been defined as “an overview of primary studies which contains an explicit statement of objectives,
materials and methods and has been conducted according to
explicit and reproducible methodology” (Greenhalgh, 1997). In
clinical medicine, such knowledge syntheses have proven “essential to advance practice and research through consolidation
of evidence” (Colquhoun et al., 2014).
The U.S. government has launched numerous initiatives for
systematic review, including the Evidence-based Practice
Centers, which perform systematic reviews of treatment interventions across a wide spectrum of health conditions, and the
U.S. Preventive Services Task Force, which performs reviews in
the area of preventive medicine, including topics related to
screening, counseling, and preventive medicines. In 2011, an
Institute of Medicine panel published recommendations for the
preparation of systematic reviews (Institute of Medicine, 2011).
Early promoters of the idea of translating the systematic review process from medicine to the field of toxicology included
Philip Guzelian, who coined the term “evidence-based toxicology,” and Thomas Hartung and Sebastian Hoffmann, who were
interested in applying the process to assessments of test
method performance/validation (Guzelian et al., 2005; Hoffmann
and Hartung, 2006). Hartung founded the Evidence-based
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assessments must address disparate data, such as different animal species and strains that may tolerate different doses, differing results (ie, an effect occurs in one species but not another),
or occupational studies conducted while exposure levels
change, eg, use of protective equipment, or changing industrial
processes.
The IRIS program’s emerging approach to systematic review
is similar to OHAT’s, and it includes a step for systematic integration of evidence for each health outcome. Both the NRC review (NRC 2014) and a subsequent workshop on the subject
suggested that guided expert judgment, coupled with structured
processes, are required for integrating IRIS evidence streams
(US Environmental Protection Agency, 2015b).
After evidence integration, IRIS assessments characterize
exposure-response relationships related to the EPA’s need for
toxicity values. The process for selecting studies to assess those
relationships is similar to that of a systematic review. The
agency is currently developing methods to combine results of
the selected studies.
Systematic reviews typically include a literature-search cutoff date, after which “late-breaking” studies are not considered.
Because IRIS evaluations are expected to consider late-breaking
studies if they would change major conclusions, the EPA has developed a process for considering pivotal studies that are published after the literature search has closed (US Environmental
Protection Agency, 2014). In general, new studies can be included until an assessment is readied for peer review. After
peer review, the presumption shifts to not including new studies unless they have an impact on the credibility of an assessment’s conclusions. Examples might be a strong new study that
indicates a heretofore undiscovered health effect, or a strong
new study that might change, in either direction, a major
conclusion.
The European Food Safety Authority (EFSA) has been using
systematic review approaches for a few years to fulfill its mandates. The Authority uses the reviews mainly for 2 different
kinds of risk assessments: (1) for the evaluation of applications
submitted with the goal of having a specific product, such as a
pesticide, feed additive, or genetically modified organism, authorized for use in the EU, and (2) for generic assessments.
Generic assessments review issues that arise within a wide
range of areas where EFSA has jurisdiction, including animal
health and welfare, plant health, feed additives, food actives,
food contact materials, and health and nutrition claims. EFSA
must also appraise systematic reviews conducted by applicants.
EFSA published its first guidance document on systematic
reviews in 2010 with a team of authors that included experts
from the Cochrane Collaboration and other groups performing
systematic reviews in relevant fields (European Food Safety
Authority, 2010). The organization has been conducting systematic review trainings.
EFSA has also produced reports on prioritizing questions for
systematic review in risk analysis and on sources of evidence
relevant for EFSA risk assessments (European Food Safety
Authority, 2015a; O’Connor et al., 2012). In 2013 and 2014, EFSA
authorized the creation of 23 systematic reviews on topics including pesticides, nutrition, feed, animal health, plant health,
contaminants, biological hazards, genetically modified organisms, and methodologies. The Authority is committed to making the data from systematic reviews publicly available.
More recently, EFSA began what it calls the PROmoting
METHods for Evidence Use in Science (Prometheus) project to
further enhance the scientific rigor of the methodological
approaches used in dealing with evidence. The project was
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Toxicology Collaboration in 2011 (Stephens et al., 2013). As in
medicine, evidence-based approaches in toxicology include not
only evidence synthesis across studies (systematic review) but
also the application of individual elements of systematic review
methodology to other contexts, such as appraising the risk of
bias of an individual article or appraising the quality of evidence
in regulatory submissions.
Among the first actual systematic reviews in toxicology and
environmental health were those conducted by Navas-Acien,
Silbergeld, and colleagues, examining the association between
exposure to environmental chemicals and human health effects
(Navas-Acien et al., 2005; Navas-Acien et al., 2006; Navas-Acien
et al., 2008). These early reviews examined in vivo, in vitro, and
epidemiological evidence to address specific questions. More recent reviews, including those by The Navigation Guide Work
Group, have further explored how these diverse data streams
could be integrated in a systematic review (Johnson et al., 2014;
Koustas et al., 2014; Lam et al., 2014; Woodruff et al., 2011).

some consideration and, potentially, guidance. The kind of expert judgment used in conducting a systematic review is and
should be separate from the kind of expert judgment involved in
making policy. A related challenge is the misperception that evidence-based approaches leave no room for professional judgment. Systematic reviews should strive to make expert
judgments clear along with the scientific basis for those judgments in developing conclusions for a systematic review.
Analyzing the approach that has been developed for involving
expert judgment in risk analysis may prove helpful in efforts to
determine how to best use expert judgment in systematic reviews for toxicology (Cooke and Goossens, 2008; Morgan, 1992).
• Workload manageability: For the EPA, which must sometimes
contend with evaluating topics that have been the subject of
thousands of studies, there is interest in finding ways to limit

load manageability without compromising evidence-based principles. There are also inherent challenges with the goals of each
review, as an evaluation of all health effects potentially associated with a chemical will be necessarily broad compared with a

䊊

䊊

䊊

Much of the data in toxicologically relevant databases is
not publicly accessible. Some study data is available in
databases that are not traditionally considered part of
the scientific literature. How to include information
from this format in systematic reviews is unclear, particularly if it is presented only in summary form. Other
concerns relate to data that is proprietary or in formats
that may not be exchangeable.
Retrieving toxicology data from PubMed is challenging
because of the lack of MeSH (Medical Subject Headings)
terms to subdivide toxicology. Therefore current best
practices include MeSH terms and text word searches to
identify the relevant literature.
In toxicology, no one information portal exists that is
analogous to the one available for evidence-based medicine’s online Cochrane Library, which provides up-todate information independently generated by practitioners throughout the world about the effectiveness of
health care interventions via 6 databases, including one
focused on systematic reviews.
Efforts are underway to encourage industry stakeholders to share detailed data without putting competitive advantage at risk.

• Risk of bias: Application of risk of bias assessment methods to
toxicology studies suggests that several possible sources of bias
(randomization of treatment, lack of allocation concealment,
and lack of blinding of outcome assessors) may be widespread
among toxicology studies (Koustas et al., 2014). This, in turn, suggests that the toxicological community should be better trained
in using study design and conduct procedures to avoid risk of
bias issues. Moreover, information from studies that generate
negative data are not always published—a form of publication
bias.

focused review of a single health effect.

Other issues:


•

Sufficient primary studies may not exist to adequately answer the review question. In these cases, the outcome of
the systematic review would identify data gaps and research needs.
Thought should be given as to who should be included on
the work groups that conduct systematic reviews or subsequent peer reviews, including whether they should include
regulators or other “customers” of systematic reviews.

WAY FORWARD
The challenges identified above to the advancement of systematic review approaches in toxicology, including issues of data
accessibility, data integration, and workload manageability, are
formidable. Recognition of these challenges is the starting point
for further discussion and priority setting. Many of the workshop speakers—who are among the vanguard of those seeking
to apply systematic review approaches in toxicology—
expressed a willingness to continue to work together closely,
where appropriate, to advance the field.
A strength of evidence-based medicine is that approaches
such as systematic review and meta-analysis are quite uniformly applied. In translating these approaches, it is important
that the safety sciences pursue a harmonized process and
avoid, where possible, major discrepancies in terminology and
approach driven by organizational preferences. A recent harmonization effort explored the similarities and differences in the
use of risk of bias methods across organizations (Rooney et al.,
2016). The EBTC is committed to fostering the necessary international dialogue to facilitate this harmonization.
For its part, the EBTC is hoping, in time, to apply systematic
review methodology to “qualify” biological pathways and pathway-based test methods for application to 21st century toxicology approaches. In this context, pertinent questions to pursue
via literature review are whether proposed pathways reflect
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the literature search at the outset of a study while still including
all truly informative studies. Some of the workload issues that
the agency must contend with may have more to do with external validity than risk of bias. The EBTC is also seeking to develop
streamlined approaches to data identification to enhance work-

The challenges currently facing the more widespread application of systematic review approaches in toxicology are
manifold.

䊊
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• Expert judgment: Exactly what constitutes the proper role for expert judgment in the context of a systemic review also merits

CHALLENGES

• Data integration: Toxicology includes a diversity of study types
providing relevant data. How and when evidence is integrated
across study types is a subject that deserves careful thought to
ensure that the process is transparent and replicable.
• Data accessibility:
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